The systemic response to surgery triggers the outgrowth of distant immune-controlled tumors in mouse models of dormancy
Patients undergoing surgical resection of primary breast tumors confront a risk for metastatic recurrence that peaks sharply 12 to 18 months after surgery. The cause of early metastatic relapse in breast cancer has long been debated, with many ascribing these relapses to the natural progression of t...
Saved in:
Published in | Science translational medicine Vol. 10; no. 436 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
11.04.2018
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | Patients undergoing surgical resection of primary breast tumors confront a risk for metastatic recurrence that peaks sharply 12 to 18 months after surgery. The cause of early metastatic relapse in breast cancer has long been debated, with many ascribing these relapses to the natural progression of the disease. Others have proposed that some aspect of surgical tumor resection triggers the outgrowth of otherwise-dormant metastases, leading to the synchronous pattern of relapse. Clinical data cannot distinguish between these hypotheses, and previous experimental approaches have not provided clear answers. Such uncertainty hinders the development and application of therapeutic approaches that could potentially reduce early metastatic relapse. We describe an experimental model system that definitively links surgery and the subsequent wound-healing response to the outgrowth of tumor cells at distant anatomical sites. Specifically, we find that the systemic inflammatory response induced after surgery promotes the emergence of tumors whose growth was otherwise restricted by a tumor-specific T cell response. Furthermore, we demonstrate that perioperative anti-inflammatory treatment markedly reduces tumor outgrowth in this model, suggesting that similar approaches might substantially reduce early metastatic recurrence in breast cancer patients. |
---|---|
AbstractList | Patients undergoing surgical resection of primary breast tumors confront a risk for metastatic recurrence that peaks sharply 12 to 18 months after surgery. The cause of early metastatic relapse in breast cancer has long been debated, with many ascribing these relapses to the natural progression of the disease. Others have proposed that some aspect of surgical tumor resection triggers the outgrowth of otherwise-dormant metastases, leading to the synchronous pattern of relapse. Clinical data cannot distinguish between these hypotheses, and previous experimental approaches have not provided clear answers. Such uncertainty hinders the development and application of therapeutic approaches that could potentially reduce early metastatic relapse. We describe an experimental model system that definitively links surgery and the subsequent wound-healing response to the outgrowth of tumor cells at distant anatomical sites. Specifically, we find that the systemic inflammatory response induced after surgery promotes the emergence of tumors whose growth was otherwise restricted by a tumor-specific T cell response. Furthermore, we demonstrate that perioperative anti-inflammatory treatment markedly reduces tumor outgrowth in this model, suggesting that similar approaches might substantially reduce early metastatic recurrence in breast cancer patients. |
Author | Ploegh, Hidde L Bierie, Brian Reinhardt, Ferenc Dougan, Michael Mercury, Oblaise A Brooks, Mary W Lambert, Arthur W Krall, Jordan A Pattabiraman, Diwakar R Dougan, Stephanie K Weinberg, Robert A |
Author_xml | – sequence: 1 givenname: Jordan A orcidid: 0000-0002-7851-6600 surname: Krall fullname: Krall, Jordan A organization: Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA – sequence: 2 givenname: Ferenc surname: Reinhardt fullname: Reinhardt, Ferenc organization: Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA – sequence: 3 givenname: Oblaise A orcidid: 0000-0002-8853-7560 surname: Mercury fullname: Mercury, Oblaise A organization: Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA – sequence: 4 givenname: Diwakar R surname: Pattabiraman fullname: Pattabiraman, Diwakar R organization: Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA – sequence: 5 givenname: Mary W surname: Brooks fullname: Brooks, Mary W organization: Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA – sequence: 6 givenname: Michael surname: Dougan fullname: Dougan, Michael organization: Division of Gastroenterology, Massachusetts General Hospital, Boston, MA 02114, USA – sequence: 7 givenname: Arthur W orcidid: 0000-0002-2989-7961 surname: Lambert fullname: Lambert, Arthur W organization: Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA – sequence: 8 givenname: Brian surname: Bierie fullname: Bierie, Brian organization: Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA – sequence: 9 givenname: Hidde L orcidid: 0000-0002-1090-6071 surname: Ploegh fullname: Ploegh, Hidde L organization: Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142, USA – sequence: 10 givenname: Stephanie K surname: Dougan fullname: Dougan, Stephanie K organization: Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA – sequence: 11 givenname: Robert A orcidid: 0000-0002-0895-3557 surname: Weinberg fullname: Weinberg, Robert A email: weinberg@wi.mit.edu organization: Ludwig Center for Molecular Oncology, Massachusetts Institute of Technology, Cambridge, MA 02142, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29643230$$D View this record in MEDLINE/PubMed |
BookMark | eNo1kMtOwzAURC0EorTwBwj5B1L8yk26RBUvqRKbsq4c-7Y1iu3KdlTl74l4rGYWc85i5uQyxICE3HO25FzAYzauJB1y79EutQ5SgbogN3yloAKhxIzMc_5iDFpZwzWZiRUoKSS7IeftEWkec0HvDE2YTzFkpCXSPKQDppGW5A5TybRMyziUQ4rncqRxT63LRYdCnfdDwMrEUFLse7S0DD5OhAvUx2HS-Wixzz9MTF4HM96Sq73uM9795YJ8vjxv12_V5uP1ff20qYxqVKm0BGOtbTqETq1EV9ewbw1jvK01KGCqtagayQUTAgG5ka2UWNuWN7XUwMSCPPx6T0M3nbM7Jed1Gnf_D4hvIWJj0A |
CitedBy_id | crossref_primary_10_2147_LRA_S240567 crossref_primary_10_3390_cancers16132304 crossref_primary_10_1016_j_euf_2019_05_013 crossref_primary_10_2340_actadv_v104_40193 crossref_primary_10_17352_2581_5407_000044 crossref_primary_10_17352_2581_5407_000043 crossref_primary_10_1016_j_clcc_2023_08_007 crossref_primary_10_3389_fonc_2020_594514 crossref_primary_10_1021_acsbiomedchemau_2c00061 crossref_primary_10_1007_s10555_021_09998_8 crossref_primary_10_1016_j_jss_2022_11_064 crossref_primary_10_3390_ijms22147356 crossref_primary_10_1016_j_jvir_2023_10_033 crossref_primary_10_1038_s42255_021_00402_x crossref_primary_10_1002_advs_202104619 crossref_primary_10_1136_bmjopen_2023_077012 crossref_primary_10_1186_s12885_024_11979_3 crossref_primary_10_1016_j_jtv_2022_08_001 crossref_primary_10_1016_j_mbs_2019_01_008 crossref_primary_10_1007_s12663_024_02411_1 crossref_primary_10_1158_2326_6066_CIR_21_0247 crossref_primary_10_3390_cancers11050592 crossref_primary_10_1172_JCI127282 crossref_primary_10_1002_cam4_4177 crossref_primary_10_1002_adhm_202100862 crossref_primary_10_1038_s41392_024_01885_2 crossref_primary_10_1158_0008_5472_CAN_19_3339 crossref_primary_10_1038_s41467_024_49059_6 crossref_primary_10_1097_SLA_0000000000003672 crossref_primary_10_1016_j_patol_2019_08_001 crossref_primary_10_3390_cells9010027 crossref_primary_10_3390_ijms25137133 crossref_primary_10_3389_fimmu_2019_01836 crossref_primary_10_1016_j_rpor_2020_04_004 crossref_primary_10_1073_pnas_2107771118 crossref_primary_10_1038_s41568_019_0209_6 crossref_primary_10_1038_s41591_020_0964_7 crossref_primary_10_1038_s41392_023_01554_w crossref_primary_10_3389_fendo_2020_567844 crossref_primary_10_3390_cells8020181 crossref_primary_10_1038_s41571_021_00540_x crossref_primary_10_1016_j_semcancer_2022_01_006 crossref_primary_10_1016_j_ijscr_2020_11_113 crossref_primary_10_1371_journal_pone_0225748 crossref_primary_10_1152_physrev_00048_2019 crossref_primary_10_1016_j_apmt_2024_102341 crossref_primary_10_1080_08941939_2021_1919945 crossref_primary_10_1158_1541_7786_MCR_21_0887 crossref_primary_10_1038_s41585_022_00608_y crossref_primary_10_14814_phy2_15497 crossref_primary_10_1002_advs_202409157 crossref_primary_10_3390_jcm9124096 crossref_primary_10_1080_09553002_2019_1625490 crossref_primary_10_1038_s41598_019_44412_y crossref_primary_10_1084_jem_20220729 crossref_primary_10_3389_fonc_2020_01399 crossref_primary_10_1016_j_cej_2024_149688 crossref_primary_10_1038_s41571_018_0134_8 crossref_primary_10_1038_s41698_024_00726_3 crossref_primary_10_15252_emmm_201708253 crossref_primary_10_1186_s12943_019_1055_6 crossref_primary_10_1126_sciadv_aaw4197 crossref_primary_10_1134_S0026893322050119 crossref_primary_10_1186_s13063_024_08159_w crossref_primary_10_3390_cancers15113021 crossref_primary_10_3390_cancers14225589 crossref_primary_10_1021_acs_langmuir_0c02219 crossref_primary_10_1080_09553002_2023_2158246 crossref_primary_10_1080_10584587_2023_2191514 crossref_primary_10_1002_advs_202207518 crossref_primary_10_1016_j_ijrobp_2022_06_095 crossref_primary_10_1038_s44222_023_00087_9 crossref_primary_10_31083_j_fbl2904152 crossref_primary_10_4251_wjgo_v17_i4_102438 crossref_primary_10_1016_j_bja_2019_09_039 crossref_primary_10_1038_nrd_2018_78 crossref_primary_10_1038_s41598_024_58236_y crossref_primary_10_1136_bmjopen_2020_040969 crossref_primary_10_3390_cancers11060851 crossref_primary_10_1002_adma_202418322 crossref_primary_10_1038_s41577_021_00571_6 crossref_primary_10_1038_s41556_024_01409_8 crossref_primary_10_1016_j_cmet_2021_07_017 crossref_primary_10_3390_biomedicines11030768 crossref_primary_10_1016_j_apsb_2021_03_035 crossref_primary_10_1016_j_mehy_2020_110157 crossref_primary_10_4037_aacnacc2021788 crossref_primary_10_1016_j_suronc_2022_101748 crossref_primary_10_1038_s41568_019_0186_9 crossref_primary_10_1038_s41578_019_0106_3 crossref_primary_10_1158_2159_8290_CD_22_0220 crossref_primary_10_3389_fimmu_2021_702785 crossref_primary_10_1016_j_critrevonc_2020_103146 crossref_primary_10_3390_healthcare11243122 crossref_primary_10_1097_MCC_0000000000000672 crossref_primary_10_1158_0008_5472_CAN_22_1199 crossref_primary_10_1245_s10434_023_13498_0 crossref_primary_10_3389_fimmu_2024_1490712 crossref_primary_10_1038_s41568_021_00395_5 crossref_primary_10_3390_biom14121496 crossref_primary_10_1016_j_actbio_2021_10_039 crossref_primary_10_1016_j_matbio_2023_07_003 crossref_primary_10_1038_s41467_019_13204_3 crossref_primary_10_3389_fimmu_2020_629722 crossref_primary_10_1016_j_biomaterials_2019_119472 crossref_primary_10_1016_j_cej_2023_145212 crossref_primary_10_1016_j_bbi_2023_01_005 crossref_primary_10_1097_ALN_0000000000003804 crossref_primary_10_3389_fonc_2021_659963 crossref_primary_10_3390_medicina56090468 crossref_primary_10_1158_2326_6066_CIR_21_0445 crossref_primary_10_1101_cshperspect_a041331 crossref_primary_10_1158_2767_9764_CRC_22_0179 crossref_primary_10_3390_ijms232213931 crossref_primary_10_14814_phy2_15813 crossref_primary_10_1093_imammb_dqaa005 crossref_primary_10_1007_s13402_019_00467_7 crossref_primary_10_1038_s41568_020_00300_6 crossref_primary_10_1080_08941939_2019_1698679 crossref_primary_10_3389_fonc_2022_798016 crossref_primary_10_3892_mmr_2023_13118 crossref_primary_10_3389_fonc_2020_614468 crossref_primary_10_1016_j_actbio_2022_04_017 crossref_primary_10_1002_adtp_201800157 crossref_primary_10_1016_j_celrep_2019_05_029 crossref_primary_10_31616_asj_2020_0637 crossref_primary_10_3389_fimmu_2020_02166 crossref_primary_10_3390_cancers12061677 crossref_primary_10_3389_fimmu_2024_1504948 crossref_primary_10_1007_s10555_024_10196_5 crossref_primary_10_5812_ijpr_123828 crossref_primary_10_3389_fimmu_2021_663115 crossref_primary_10_12677_acm_2025_153604 crossref_primary_10_2174_0929867331666230727100123 crossref_primary_10_1245_s10434_020_09371_z crossref_primary_10_3390_cancers13092026 crossref_primary_10_1016_j_canlet_2020_04_004 crossref_primary_10_1038_s42255_020_00277_4 crossref_primary_10_3390_cancers13092140 crossref_primary_10_1016_j_bjps_2023_04_012 crossref_primary_10_1038_s43018_020_0088_5 crossref_primary_10_18632_oncotarget_26903 crossref_primary_10_1016_j_compbiomed_2025_109885 crossref_primary_10_1016_j_semcancer_2019_07_021 crossref_primary_10_3389_fonc_2022_866890 crossref_primary_10_3390_cancers13153918 crossref_primary_10_1016_j_medcle_2018_11_024 crossref_primary_10_1038_s41577_023_00836_2 crossref_primary_10_3390_jpm10040227 crossref_primary_10_1002_jbmr_3618 crossref_primary_10_1016_j_pharmthera_2019_04_005 crossref_primary_10_1038_s41467_020_17565_y crossref_primary_10_1016_j_semcancer_2019_07_027 crossref_primary_10_1002_advs_201801987 crossref_primary_10_1016_j_jconrel_2022_04_015 crossref_primary_10_1016_j_medcli_2018_11_010 crossref_primary_10_1159_000502778 crossref_primary_10_14302_issn_2692_1537_ijcv_21_4053 crossref_primary_10_1016_j_rbmo_2021_04_017 crossref_primary_10_1073_pnas_2007412117 crossref_primary_10_1360_SSV_2022_0058 crossref_primary_10_1016_j_semcancer_2021_05_007 crossref_primary_10_1038_s41423_020_0449_0 crossref_primary_10_3389_fcell_2020_598620 crossref_primary_10_1016_j_critrevonc_2022_103729 crossref_primary_10_1016_j_oraloncology_2024_106705 crossref_primary_10_1038_s41388_020_1295_3 crossref_primary_10_1002_nbm_4053 crossref_primary_10_1007_s10585_021_10144_5 crossref_primary_10_1136_jitc_2022_006589 crossref_primary_10_3390_cancers15133381 crossref_primary_10_3390_ijms24054974 crossref_primary_10_1038_s41467_019_09015_1 crossref_primary_10_3390_cancers12092594 crossref_primary_10_3390_ijms232113217 crossref_primary_10_1016_j_tips_2018_12_004 crossref_primary_10_1158_2159_8290_CD_21_0010 crossref_primary_10_1007_s10555_023_10085_3 crossref_primary_10_1016_j_saa_2025_125743 crossref_primary_10_1053_j_gastro_2024_05_028 crossref_primary_10_1016_j_ijpharm_2024_123897 crossref_primary_10_1016_j_jtbi_2023_111582 crossref_primary_10_1186_s12967_020_02348_2 crossref_primary_10_28982_josam_1003837 crossref_primary_10_3389_fonc_2025_1430761 crossref_primary_10_3390_cancers12010011 crossref_primary_10_1016_j_mehy_2022_110900 crossref_primary_10_3390_s20247261 crossref_primary_10_1016_j_advms_2024_02_006 crossref_primary_10_1080_09553002_2021_1955998 crossref_primary_10_1186_s12943_019_1058_3 crossref_primary_10_1021_acs_bioconjchem_2c00548 crossref_primary_10_34175_jno201904004 crossref_primary_10_1186_s13048_021_00895_w crossref_primary_10_3389_fonc_2023_1175580 crossref_primary_10_3389_fmolb_2018_00076 crossref_primary_10_1038_s41556_018_0145_9 crossref_primary_10_1016_j_breast_2019_03_001 crossref_primary_10_1002_EXP_20220173 crossref_primary_10_1016_j_adro_2022_100909 crossref_primary_10_18632_oncotarget_26487 crossref_primary_10_3389_fimmu_2022_855978 crossref_primary_10_3389_fonc_2024_1412367 crossref_primary_10_1016_S1470_2045_21_00401_0 crossref_primary_10_1016_j_ejso_2023_06_019 crossref_primary_10_3390_cancers13225621 crossref_primary_10_1242_dmm_050542 crossref_primary_10_1038_s41568_018_0017_4 crossref_primary_10_15252_emmm_202114283 crossref_primary_10_1007_s00262_024_03800_8 crossref_primary_10_1016_j_bbcan_2019_06_002 crossref_primary_10_2147_CMAR_S322569 crossref_primary_10_1002_acm2_12620 crossref_primary_10_1093_stcltm_szad043 crossref_primary_10_1038_s41392_022_01057_0 crossref_primary_10_1126_scisignal_aay8690 crossref_primary_10_2174_1871520622666220831124321 crossref_primary_10_1177_1535370218820287 crossref_primary_10_1007_s13304_022_01312_7 crossref_primary_10_1016_j_molstruc_2025_142002 crossref_primary_10_1038_s41423_021_00742_4 crossref_primary_10_1111_vco_12636 crossref_primary_10_1016_j_canlet_2020_06_012 crossref_primary_10_1084_jem_20202595 crossref_primary_10_1002_med_21967 crossref_primary_10_1016_j_xcrm_2023_101113 crossref_primary_10_1213_ANE_0000000000007328 crossref_primary_10_1002_adma_202105254 crossref_primary_10_1172_jci_insight_123281 crossref_primary_10_3389_fsurg_2023_1112473 crossref_primary_10_1158_1541_7786_MCR_23_0265 crossref_primary_10_1016_j_cub_2020_03_054 crossref_primary_10_1097_SLA_0000000000003255 crossref_primary_10_3390_cancers17010049 crossref_primary_10_1186_s12967_019_02177_y crossref_primary_10_1097_PPO_0000000000000361 crossref_primary_10_1016_j_jtho_2020_08_014 crossref_primary_10_1016_j_apmt_2022_101584 crossref_primary_10_1038_s41568_021_00347_z crossref_primary_10_3390_curroncol29110698 crossref_primary_10_1007_s11427_018_9396_x crossref_primary_10_1186_s13073_022_01138_3 crossref_primary_10_2147_IJN_S341394 crossref_primary_10_1007_s11914_019_00532_y crossref_primary_10_1002_advs_201903616 crossref_primary_10_1007_s00383_024_05788_9 crossref_primary_10_1039_D1BM01607E crossref_primary_10_3390_cancers11081207 crossref_primary_10_1039_D3QM00239J crossref_primary_10_3390_cancers11060745 crossref_primary_10_1158_0008_5472_CAN_22_1902 crossref_primary_10_3389_fams_2020_00027 crossref_primary_10_1158_2767_9764_CRC_23_0447 crossref_primary_10_3390_cells10112826 crossref_primary_10_1007_s00761_018_0469_x crossref_primary_10_1007_s40140_018_0296_z crossref_primary_10_1172_JCI129705 crossref_primary_10_1002_adfm_202213151 crossref_primary_10_3390_ph17010051 crossref_primary_10_1016_j_biomaterials_2019_04_022 crossref_primary_10_1111_imr_13231 crossref_primary_10_1016_j_immuni_2019_06_025 crossref_primary_10_1016_j_urolonc_2022_09_021 crossref_primary_10_1242_dev_181636 crossref_primary_10_1016_j_suronc_2018_11_009 crossref_primary_10_1111_brv_12490 crossref_primary_10_1007_s12609_022_00448_0 crossref_primary_10_3390_ijms21031159 crossref_primary_10_1016_j_ebiom_2019_07_058 crossref_primary_10_3390_cancers15153755 crossref_primary_10_1016_j_semcancer_2021_02_002 crossref_primary_10_1016_j_semcancer_2021_02_001 crossref_primary_10_1016_j_cej_2022_135711 crossref_primary_10_1007_s11033_023_08768_9 crossref_primary_10_1186_s12957_023_02887_0 crossref_primary_10_3390_ijms20246158 crossref_primary_10_1371_journal_pgph_0001125 crossref_primary_10_1097_SAP_0000000000003405 crossref_primary_10_1097_COC_0000000000000791 crossref_primary_10_3390_cells13131087 crossref_primary_10_1002_adfm_202300058 crossref_primary_10_1016_j_currproblcancer_2020_100700 crossref_primary_10_2217_rme_2020_0072 crossref_primary_10_1038_s41423_019_0306_1 crossref_primary_10_1371_journal_pbio_3002297 crossref_primary_10_1016_j_biomaterials_2019_119649 crossref_primary_10_1158_0008_5472_CAN_20_3222 crossref_primary_10_3389_fonc_2024_1336031 crossref_primary_10_1158_0008_5472_CAN_19_3631 crossref_primary_10_14302_issn_2471_7061_jcrc_22_4139 crossref_primary_10_1002_adtp_201900195 crossref_primary_10_1073_pnas_2314085121 crossref_primary_10_1172_JCI143765 crossref_primary_10_2174_1389450121999201013152931 crossref_primary_10_1038_s41419_019_1600_7 crossref_primary_10_1088_1361_6633_abcd7b crossref_primary_10_3390_jcm13061546 crossref_primary_10_1002_ctm2_24 crossref_primary_10_1016_j_breast_2020_05_002 crossref_primary_10_1098_rsob_210245 crossref_primary_10_1016_j_ijbiomac_2021_11_186 crossref_primary_10_3390_cancers14030547 crossref_primary_10_3390_cells10020454 crossref_primary_10_1016_j_pharmthera_2020_107670 crossref_primary_10_1186_s13036_018_0120_9 crossref_primary_10_3390_cells13232022 crossref_primary_10_3390_ijms19113333 |
ContentType | Journal Article |
Copyright | Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. |
Copyright_xml | – notice: Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1126/scitranslmed.aan3464 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1946-6242 |
ExternalDocumentID | 29643230 |
Genre | Research Support, U.S. Gov't, Non-P.H.S Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NCI NIH HHS grantid: K99 CA201574 |
GroupedDBID | --- 0R~ 4.4 53G 7~K ABJNI ACGFS AENEX AFQFN AJGZS AJWWR ALMA_UNASSIGNED_HOLDINGS BKF C45 CGR CUY CVF DU5 EBS ECM EIF EJD EMOBN F5P HZ~ NPM O9- OFXIZ OVD OVIDX P2P RHI TEORI |
ID | FETCH-LOGICAL-c474t-a36cddd7be6b492b556f8c00185a646048de47312022e6e1c3833e5d81753a602 |
IngestDate | Mon Jul 21 05:58:27 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 436 |
Language | English |
License | Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c474t-a36cddd7be6b492b556f8c00185a646048de47312022e6e1c3833e5d81753a602 |
ORCID | 0000-0002-1090-6071 0000-0002-0895-3557 0000-0002-2989-7961 0000-0002-7851-6600 0000-0002-8853-7560 |
OpenAccessLink | https://stm.sciencemag.org/content/scitransmed/10/436/eaan3464.full.pdf |
PMID | 29643230 |
ParticipantIDs | pubmed_primary_29643230 |
PublicationCentury | 2000 |
PublicationDate | 2018-04-11 |
PublicationDateYYYYMMDD | 2018-04-11 |
PublicationDate_xml | – month: 04 year: 2018 text: 2018-04-11 day: 11 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Science translational medicine |
PublicationTitleAlternate | Sci Transl Med |
PublicationYear | 2018 |
References | 29713084 - Nat Rev Cancer. 2018 Jul;18(7):404-405 |
References_xml | – reference: 29713084 - Nat Rev Cancer. 2018 Jul;18(7):404-405 |
SSID | ssj0068356 |
Score | 2.6433182 |
Snippet | Patients undergoing surgical resection of primary breast tumors confront a risk for metastatic recurrence that peaks sharply 12 to 18 months after surgery. The... |
SourceID | pubmed |
SourceType | Index Database |
SubjectTerms | Animals Biomarkers, Tumor - immunology Biomarkers, Tumor - metabolism Breast Neoplasms - immunology Breast Neoplasms - metabolism CD8-Positive T-Lymphocytes - metabolism Cell Line, Tumor Female Mice Neoplasm Metastasis - immunology Neoplasm Recurrence, Local - immunology Neoplasm Recurrence, Local - metabolism |
Title | The systemic response to surgery triggers the outgrowth of distant immune-controlled tumors in mouse models of dormancy |
URI | https://www.ncbi.nlm.nih.gov/pubmed/29643230 |
Volume | 10 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9tAEF6cFEovpe9XWvbQm1GwvavV6liahNDSByWB3MI-RqmIIwd3TaB_qX-yM7srx7Hb0vYihBYJS_N5dl7fDGOvHaFIurJQrqwK3CHqQvuIZS-UNiPT2Njt86M6PJbvTsqTweDHStXSIthd9_2XvJL_kSpeQ7kSS_YfJLt8KF7Ac5QvHlHCePxrGadWzLERc6x2jaMwviWy8zCg731GFF0yL2eLcIZOd_hKBqInu7ELw5b4IVDkivUpmp9hcUEDeNpuSFEBSLNyYsGHTwyDG4ngXjcE2vOmfWRxPWP_fm5yMQ36uqhRlrD5Am1HvK-4FRxE6uESAjB3Ocn_yU4pw3V922cTgrHt3OT47V57Zc7NPFc_5iDGWFM-JitZSIq3lqogrsoNzTxaQaBMjVI2VX4_pDK9KL7grjGdkKk5-goKLi8iDCjPLCYpGfTn1bVG3P3SFttCl4RmrFJgKG36Cg1ZlZmZmZO18XOo73R-xJoPE22Zo3vsbnZC-JuEqPtsAN0DdvtDFtpDdoXA4j2weA8sHmY8A4v3wOIILL4EFp81PAOLbwCLJ2DxtuMRWDwBK96TgfWIHR_sH709LPKEjsLJSobCCOW895UFZWU9sWWpGu1o0GNplFS4O3iQlRhP0FIEBWMntBBQek39YY0aTR6z7W7WwVPGAWppoNZNpaknpK9pqFrldGUbURqonrEn6ZOdXqY2LKf9x3z-25UX7M412HbYrQb_9_ASjchgX0Xx_QRvJXvg |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+systemic+response+to+surgery+triggers+the+outgrowth+of+distant+immune-controlled+tumors+in+mouse+models+of+dormancy&rft.jtitle=Science+translational+medicine&rft.au=Krall%2C+Jordan+A&rft.au=Reinhardt%2C+Ferenc&rft.au=Mercury%2C+Oblaise+A&rft.au=Pattabiraman%2C+Diwakar+R&rft.date=2018-04-11&rft.eissn=1946-6242&rft.volume=10&rft.issue=436&rft_id=info:doi/10.1126%2Fscitranslmed.aan3464&rft_id=info%3Apmid%2F29643230&rft_id=info%3Apmid%2F29643230&rft.externalDocID=29643230 |